Truth: Whooping Cough in the U.S.

The approach to Whooping cough is eerily parallel to the approach the medical and healthcare industrial complex took to COVID - you have been warned, you can take action in your State...

Prologue: Why We Are Publishing This Report

We were in the same boat as everyone else when COVID-19 struck (C19) - but not for very long. The discernment in separating commnds and demands quickly isolated where the fear-mongering was coming from so we sought resources who had the same discernment.

What we also saw were patterns being repeated through the histories of everything related to healthcare and the medical profession - patterns that were repeated since the 1800s and always leading to the same result: the cure was more lethal than the cause.

We are seeing the same thing with the so-called Bird flu and now the Whooping cough.

The mechanism for getting knowledge out to people is the media - social media, local news, national news - and the voices you listen to determine what you believe, even if that belief is a fabricated lie meant to make you believe them.

If they want to ignore the opportunity to examine their beliefs, that is an age-old problem that even an intellect will make their entire life.

We highly suggest you bookmark this post, and after its publication, we will be making it available in PDF, adding a link at the end of the post.

Any updates to this post will be published in a new post with a link back to this one for the sake of reference, as well as those who missed this post on the first go around.

At the end of this post is a CALL TO ACTION - the ONLY way to get ahead of an anticipated problem is to get ahead of those who can influence what could go down by educating them on the truth.

VIDEO: The Truth About Whooping Cough in the U.S.

Barbara Loe Fisher, NVIC Co-founder & President, talks about the risks and failures of pertussis (whooping cough) vaccine in whole cell DPT and acellular DTaP/Tdap shots and how misinformation is wrongly placing blame on parents of unvaccinated children for pertussis outbreaks when pertussis is occurring in undiagnosed vaccinated persons.

Click the image below for the video on this report on the NVIC Rumble channel

by and all rights belong to Barbara Loe Fisher, National Vaccine Center, May 01, 2025

As with any long post, gMail will truncate this post. For those using gMail, please click the headlines to read this online. We highly recommend Proton Mail, which can be obtained here: Proton.me. We receive no revenue for promoting Proton products.

Once again, this year Americans are being warned that B. pertussis whooping cough cases are on the rise and society is being endangered by parents who don’t vaccinate their children. ^{1 2 3 4 5}

That myth goes back to the early 1980’s, when parents of DPT vaccine injured children in the U.S. were calling for a less reactive pertussis vaccine because our children were dying and being brain injured by the crude whole cell pertussis vaccine, ^{6 7} an especially toxic vaccine that is still being given today in some other countries. ⁸

In the late 20^th century we were accused of causing whooping cough outbreaks just by talking about crippling DPT vaccine reactions, ⁹ very similar to the accusations leveled against people who talked about crippling COVID shot reactions that led to widespread censorship of freedom of speech in the 21^st century. ^{10 11 12 13}

Back in the 1980s, while we were researching the medical literature and learning about how the DPT vaccine could kill and disable children, we were also discovering that the whole cell pertussis vaccine was not reliably preventing infection with or transmission of B pertussis that causes whooping cough. ¹⁴

In the early 1980s, scientists were reporting that whole-cell pertussis vaccine acquired immunity lasted only about 2 to 5 years, and whooping cough was circulating in countries with 90 to 95% vaccination rates, including in people showing few or no symptoms. ^{15 16 17 18 19 20 21 22}

Cases of asymptomatic transmission of whooping cough were not being counted in official pertussis statistics in the 1980s when nearly every child in the U.S. was getting 4 or 5 doses of whole-cell pertussis vaccine. ²³

And today, cases of asymptomatic whooping cough in children and adults, who have gotten 5 to 7 doses of acellular pertussis vaccine, are not being counted either. ²⁴

Public health officials and doctors continue to insist publicly that vaccines do prevent infection and transmission of disease. ^{25 26}

In fact, the utilitarian rationale for mandatory vaccination laws is based on the premise that everyone must be forced to get vaccinated, that it is our moral obligation to be willing to sacrifice our lives or the lives of our children by risking a disabling or life-ending vaccine reaction for the greater good of society. ^{27 28 29}

The argument is that forcing everyone to get vaccinated creates “herd” or “community” immunity,^{30 31} and society is protected from infection and transmission of diseases, which public health officials always claim have more serious and frequent complications than vaccines. ³²

So the scientific and moral rationale for mandatory vaccination rises or falls on whether or not vaccines reliably prevent infection with and transmission of diseases caused by microbes.

During the coronavirus pandemic declaration in 2020, public health officials and lawmakers mandating the COVID shot insisted that none of us would get sick or make other people sick if we rolled up our sleeves and got COVID shots. ^{33 34 35}

But soon it became painfully clear that the mRNA biological product labeled a COVID vaccine did not prevent the disease, ³⁶ no matter how many COVID shots a person got, ³⁷ and the risks for heart and brain inflammation were significant.^{38 39 40 41}

Infectious microbes adapt to survive and circulate in human and animal hosts.^{42 43}

The truth is that you can get vaccinated according to the CDC’s recommended schedule and still get pertussis,⁴⁴ measles,^{45 46} mumps,⁴⁷ influenza⁴⁸and other vaccine-targeted diseases, but only show few symptoms or no symptoms at all.

Vaccinated and unvaccinated people can also transmit infection to other vaccinated and unvaccinated people, even as there is mounting evidence that a natural infection often provides a more robust and longer-lasting immunity than a vaccine.^{49 50 51}

Pertussis is an excellent example.

Since 1986, I have been talking about the fact that the pertussis vaccine does not reliably prevent infection and transmission of whooping cough.

In 1986, when our organization - then known as Dissatisfied Parents Together (DPT) – held the first public demonstration in front of the Centers for Disease Control (CDC) in Atlanta to protest the reactivity of whole cell pertussis vaccine, I gave an oral presentation to the Advisory Committee on Immunization Practices (ACIP) summarizing an investigation I had conducted into DPT vaccine failures in 8 states reporting whooping cough outbreaks.

I presented data obtained from the 8 state health departments, which revealed that in 6 out of 8 states, more than half of the reported cases of whooping cough in children and adults had been vaccinated.

In 1 state, more than 70% of the whooping cough cases with a known vaccination history had received three or more DPT shots. ⁵²

Time to Dispel Myths and Lies About Pertussis and Pertussis Vaccines

What’s old is new, and it is time to dispel the myths and lies being told about the old whole-cell and newer acellular pertussis vaccines.

• FACT: Both the highly reactive whole cell DPT vaccine licensed 1948, ⁵³ and the less reactive acellular DTaP vaccine licensed in 1996 for infants ⁵⁴ can fail to prevent infection and transmission. ⁵⁵ Those 2 vaccines typically provide 2 to 5 years of temporary vaccine acquired immunity – at best lasting about 12 years; ^{56 57 58}

• FACT: Natural infection with B. pertussis often produces a more robust and longer lasting immunity of between four and 20 years – at best 30 to 70 years; ⁵⁹

• FACT: An unknown number of vaccinated children and adults – perhaps millions - are silently infected with pertussis in the U.S. every year and show few or no symptoms and doctors do not identify those cases, which means those cases are not reported to the government; ^{60 61}

• FACT: In response to mass pertussis vaccination campaigns beginning in the 1950s, the B. pertussis microbe evolved first to evade whole cell pertussis vaccines in the 1980s and, in the 1990s, that evolution accelerated to evade acellular pertussis vaccines. ⁶²

Now, here is the rest of the story in more detail…

High Child Pertussis Vaccination Rates in U.S. for 35 Years

Child pertussis vaccination rates in the U.S. for children attending school have remained high and relatively stable for the past 45 years.

Consistently, more than 90 to 94% of kindergarten children have received 4 to5 pertussis-containing shots either in whole-cell DPT or acellular DTAP. ⁶³

In the 2023-2024 school year, nationally 92% of children attending kindergarten had gotten 5 doses of pertussis containing DTaP, with 1 state reporting a more than 98% vaccination rate. ⁶⁴

Among 24-month-old children, there was a 94% pertussis vaccination rate with 3 doses of DTaP and 81% with 4 doses in the years 2019 and 2020. ⁶⁵

Today, 89% of teenagers attending high school have gotten at least 1 Tdap booster shot. ⁶⁶

That’s a lot of pertussis vaccination going on in America for a long time among children of all ages, many of whom are now adults in their 20s, 30s, and 40s.

So, why beginning a decade ago, did public health officials report that large numbers of fully vaccinated pre-schoolers in Florida, ⁶⁷ and fully vaccinated teenagers in California, ⁶⁸ and fully vaccinated sisters and brothers of newborn infants were spreading pertussis whooping cough - ⁶⁹ even though most had gotten every pertussis shot recommended by the CDC?

To answer that question, let’s do a quick review of the history of pertussis and pertussis vaccine.

DPT Licensed in 1948 & DTaP in 1996 for U.S. Babies

Pertussis whooping cough has been around since at least the 15^th century, ⁷⁰ and it can be deadly for babies who cannot breathe when the sticky mucous produced by the gram negative bacteria clogs their tiny airways.

Signs of whooping cough begin with typical cold symptoms of fatigue, runny nose, sometimes a low-grade fever, and a slight cough for several weeks.

It progresses to violent spasmodic coughing that ends with a “whoop” in infants or small children as they try to breathe and then vomit up thick mucus through the nose and mouth, especially at night.

Historically referred to as “the 100-day cough,” a pertussis infection can last for four to 12 weeks, and serious complications include bronchitis, pneumonia, brain inflammation, and death.

Doctors prescribe antibiotics, and there are holistic therapies, but the course of the disease is rarely altered, and rehydration, rest, and good nutrition are always recommended. ⁷¹

The first crude whole cell pertussis vaccine, which contained bioactive pertussis toxin and endotoxin, was licensed in 1914, but was not given widely to children until after 1948, when it was combined with diphtheria and tetanus vaccines into the DPT shot that also contained aluminum and mercury. ⁷²

DPT was used in the U.S. until 1996, when a purified, less reactive acellular pertussis vaccine (DTaP) was licensed for use by infants. ⁷³

Acellular pertussis vaccines contain far less bioactive pertussis toxin and endotoxin and do not contain mercury. ^{74 75 76}

While DTaP has been proven to be far less reactive than whole cell pertussis vaccine in DPT, ^{77 78 79 80 81} acellular pertussis vaccine can still cause brain inflammation and permanent brain dysfunction in vulnerable individuals. ^{82 83 84 85 86}

In 2019, World Health Organization (WHO) officials reported that 86% of the world’s infants had received at least 3 pertussis-containing shots. ⁸⁷

75% Drop in Pertussis Deaths Before DPT Licensed in 1948

But what about deaths in the U.S. from B. pertussis whooping cough?

In our country, deaths from pertussis infections dropped by more than 75% between 1922 and 1948, the year the DPT vaccine was licensed.

In 1948, the mortality rate was less than 1 pertussis death per 100,000 persons and would never be higher than that again in the U.S. ^{88 89}

In 2013, there were about 29,000 reported pertussis cases and 13 pertussis-related deaths in America, with 9 of those deaths in infants under age one. ⁹⁰

By the end of 2024, there had been more than 35,000 pertussis cases reported in the U.S. out of 326 million people, with 10 related deaths, and 6 of those deaths in infants under age one. ⁹¹

However, reported numbers of pertussis cases do not match the total number of actual cases of pertussis that are happening in America.

Most pertussis cases, like most vaccine reactions, are not being diagnosed or reported by doctors to the government.^{92 93}

Public health officials admit they still don’t have reliable lab tests to measure pertussis immunity, and, although there have been recent improvements in diagnostic tests, there is little agreement about how to diagnose pertussis when infected people, especially vaccinated people, show up in doctors’ offices with mild symptoms. ^{94 95 96}

The truth is that the child or adult sitting next to you in the bus, classroom, movie theater or doctor’s office, who has a little cough or no cough at all, could be infected with B. pertussis whooping cough, even though he or she has gotten every federally recommended dose of pertussis vaccine.

U.S. Pertussis Cases in Vaccinated Persons Not Identified or Reported

When people can have silent asymptomatic infections, it means that reported cases of infectious diseases, like pertussis, are just the tip of a very big iceberg. ⁹⁷

It means that articles blaming whooping cough cases on unvaccinated or partially vaccinated children are nothing more than wishful thinking and scapegoating. ^{98 99}

---

BOTTOM LINE:

Naturally acquired and vaccine-acquired immunity are not lifelong.

The B. pertussis microbe circulates among both vaccinated and unvaccinated individuals.

While vaccination may prevent clinical symptoms, it does not reliably block infection, carriage, or transmission.

If vaccinated people can get silently infected and transmit infection without showing any symptoms – even after getting four to six pertussis shots - then the idea of pertussis vaccine-acquired “herd immunity” is an illusion and always has been.

So why has more than a century of pertussis vaccination failed to produce vaccine-acquired herd immunity, as public health officials insist that theoretically it can if only more and more pertussis shots are given to more people more of the time?

---

Extremely Reactive DPT and Less Reactive DTaP both Have Low Efficacy

The emerging scientific evidence is compelling: the B. pertussis microbe has evolved over the past century to evade whole-cell and acellular pertussis vaccines, which drug companies have marketed and medical doctors have aggressively promoted in a crusade to eradicate a species of bacteria they still know very little about. ^{100 101 102}

A review of the medical literature reveals that the experts are unhappy with how much they still don’t know about the B. pertussis microbe and are arguing with each other about if, when, how and why pertussis vaccines have consistently failed to do the job of preventing B. pertussis whooping cough from circulating in highly vaccinated populations around the world. ^{103 104}

The inconvenient set of scientific facts they have to work with is these:

• FACT: The efficacy of whole cell pertussis vaccine in the DPT shot was measured to be between 30 and 85%, depending upon the type of DPT and vaccine manufacturer, ^{105 106 107 108} and protection on average lasted 2 to 5 years. ¹⁰⁹
  

• FACT: After a low of about 1,000 cases of pertussis were reported in the U.S in 1976, ¹¹⁰ it was obvious all through the 1980s and 90s that whole cell pertussis vaccine in DPT shots was not reliably preventing infection or transmission of whooping cough. ^{111 112 113 114 115}
  
  Pertussis cases increased in highly vaccinated populations in cycles of 3 to 5 years, ¹¹⁶ - just like before DPT vaccine was widely used in the 1950s. ^{117 118 119 120}
  

• FACT: The whole cell DPT vaccine used until the late 1990’s in the U.S. was an extremely reactive vaccine.
  

  DPT vaccine reactions like fever, pain, and irritability were experienced by between 50 and 85% of children, and seizures and collapse/shock reactions followed one in 875 DPT shots. ^{121 122}
  
  Brain inflammation was reported following 1 in 110,000 DPT shots with permanent brain damage after 1 in 310,000 DPT shots. ^{123 124}
  
  Finally, in 1996, the marginally effective and extremely reactive whole-cell DPT vaccine was replaced with a far less reactive but marginally effective acellular DTaP vaccine. ¹²⁵
  
  Similar to whole-cell pertussis vaccines, acellular pertussis vaccine efficacy in clinical trials was measured to be between 40 and 89%, depending on the DTaP vaccine manufacturer. ^{126 127 128}
  

• FACT: Acellular pertussis vaccines do not reliably prevent infection,^{129 130} just like whole cell pertussis vaccines do not reliably prevent infection. ¹³¹
  
  In the 21^st century, pertussis outbreaks and cyclical increases have continued, ¹³² – even after a pertussis booster shot was added to the schedule for all adolescents and adults in 2006. ^{133 134}
  
  By 2010, the Tdap pertussis booster shot was found to be only about 66% effective in providing temporary immunity for teenagers and adults. ¹³⁵

Pertussis Microbe Evolved to Evade Both DPT and DTaP Vaccines

In 1998, molecular biologists and other basic science researchers began warning that the B. pertussis microbe started to evolve to evade whole whole-cell pertussis vaccine after DPT shots were given on a mass basis to children in the 1950s. ^{136 137 138 139 140}

These bench scientists have been publishing hard evidence that during the past 65 years, B. pertussis bacteria have efficiently adapted to both whole-cell and acellular pertussis vaccines. ^{141 142 143}

New Pertussis Strains with More Toxin Causing More Serious Disease

In a fight to survive, some evidence suggests the B. pertussis microbe has created new strains that produce more pertussis toxin to suppress the human immune system and cause more serious disease. ¹⁴⁴

Today, the pertussis strains included in the vaccine provide less of a match for the pertussis strains causing whooping cough disease. ^{145 146 147 148}

---

BOTTOM LINE:

There is scientific evidence that B. pertussis bacteria have evolved to survive vaccine pressure, and there is some concern that more virulent pertussis strains may evolve to be more efficiently transmitted by vaccinated children and adults with waning immunity.

As one research scientist commented in 2009,

“An important question is whether other childhood vaccines also select for pathogens that are more efficiently transmitted by primed hosts, resulting in increased virulence.” ¹⁴⁹

---

New Genetically Engineered Pertussis Vaccines: The Cure Worse Than the Disease?

The crusade by public health officials to eradicate the B. pertussis microbe by adding more and more doses of ineffective vaccines to the child and adult schedule – even invading the once sacred place of the womb and insisting all pregnant women be vaccinated with pertussis containing vaccines ^{150 151} – has not been proven to be effective, safe or necessary. ^{152 153}

Every vaccine comes with a risk of injury or death, which can be greater for some individuals depending upon the ancestral genes they were born with, ^{154 155} their epigenetic history, ¹⁵⁶ the state of their microbiome ^{157 158} , and other individual biological and environmental susceptibilities. ¹⁵⁹

As we witness a bacterial species efficiently adapting to survive a war that has been declared on it by humans, what has become painfully clear is that the history of mass vaccination has not been driven by hard science transparently shared with the people. ¹⁶⁰

It has been driven by the politics of a Public Health Empire (aka Medical and Healthcare Industrial Complex) working a lucrative government-industry public-private business partnership to protect failed mandatory vaccination laws, while ignoring the hard science.¹⁶¹

Scientists are creating new pertussis vaccines using genetically modified pertussis bacteria that predictably will be fast-tracked to market in a quest to put more pressure on the B. pertussis microbe to drive it from the planet. ¹⁶²

The 1st targets will be pregnant women and children.

One of these is a nasal pertussis vaccine using a lipid nanoparticle adjuvant developed with NIH funding, designed to hyperstimulate an immune response. ¹⁶³

The COVID shot uses lipid nanoparticles to deliver synthetic mRNA into the body’s cells and hyperstimulate an immune response. ^{164 165}

That controversial mRNA technology is being used to develop another new pertussis vaccine, ¹⁶⁶ it is a technology which has been associated with more than 1.5 million COVID shot reaction reports to the Vaccine Adverse Event Reporting System known as VAERS.

Will these new genetically engineered pertussis vaccines create a cure that is worse than the disease?

In 1960, Swedish scientist Justis Strom, MD, wrote in the British Medical Journal that there were more complications from the pertussis vaccine than there were complications from reported cases of pertussis in Sweden. He said: ¹⁶⁷

The increasingly mild nature of whooping cough and the very low mortality in this disease in Sweden make it questionable whether universal vaccination against it is justified. This same question may perhaps arise in some other countries.

CALL TO ACTION: Show Us the Science and Give Us A Choice

Whatever the pharmaceutical industry and public health officials choose to do, it is up to each one of us to remind lawmakers that it is their responsibility to show us the science and give us a choice when it comes to vaccines, especially when the National Childhood Vaccine Injury Act of 1986 has been destroyed by Congress and by federal agency rule making and by the U.S. Supreme Court so that no vaccine manufacturer, no public health official and no doctor is liable in a civil court of law when vaccine reactions or failures lead to injury and death. ¹⁶⁸

Voluntary, informed consent to medical risk taking, including to vaccination, is a human right. ¹⁶⁹

Learn more on NVIC.org.

Sign up for the free NVIC Advocacy Portal and become active in your state to oppose vaccine mandates and protect vaccine exemptions from being eliminated by the Pharma, Medical Trade, and Public Health industries.

It’s your health. Your family. Your choice.

And our mission continues: No forced vaccination. Not in America.

Sources

¹ Eldeib D, Callahan P. ‘Not just measles’: Whooping cough cases are soaring as vaccine rates decline. CNN Apr 14, 2025.

² CDC. Pertussis Surveillance and Trends. Apr. 22, 2025.

³ Kekatos M. Whooping cough cases have doubled in a year, CDC data shows. ABC News Apr. 24, 2025.

⁴ Bose D. Whooping cough cases are rising again in the U.S. Associated Press Apr. 25, 2025.

⁵ Appes J. As cases rise nationally, 2 infants die of pertussis in Louisiana. CIDRAP Apr. 3, 2025.

⁶ Sugawara S. Two Parent Groups Speak Out Against Multiple DPT Vaccine: Side Effects Blamed for Brain Damage. Washington Post Feb. 7, 1985.

⁷ Killacky J. State Group Questions Safety of DPT Shots for Children. The Oklahoman Sept. 21, 1986.

⁸ United Nations. Diphtheria Tetanus and Pertussis Containing Vaccines: Market and Supply Update, UNICEF Supply Division June 2023.

⁹ Associated Press. Medical Panel Finds A Doubling of Cases of Whooping Cough. New York Times Nov. 17, 1985.

¹⁰ Davis M. Big Tech Censorship of COVID Information Leads to Vaccine Hesitancy. Newsweek Nov. 21, 2021.

¹¹ Soave R. Inside the Facebook Files: Emails Reveal the CDC’s Role in Silencing COVID-19 Dissent. Reason Magazine Jan. 19, 2023.

¹² Fisher BL. Blacklisting and Censorship Violates Freedom of Thought, Speech and Conscience. National Vaccine Information Center Nov 1, 2023.

¹³ Office of Senator Ron Johnson. PSI Chairman Johnson to Meta CEO Zuckerberg: Turn Over Facebook Records on Censorship of COVID-19 Vaccine Injured. Press Release: Feb. 6, 2025.

¹⁴ Broome CV, Preblud SR, Bruner B et al. Epidemiology of pertussis, Atlanta, 1977. J Pediatr 1981; 98(3): 362-367.

¹⁵ Fine PEM, Clarkson JA. The Recurrence of Whooping Cough: Possible Implications for Assessment of Vaccine Efficacy . The Lancet 1982; 1(8273): 666-669.

¹⁶ Trollfors B. Bordetella pertussis whole cell vaccines – efficacy and toxicity. Acta paediatrica Scandinavia 1984; 73(4): 417-425.

¹⁷ Transcript (partial) of May 12, 1986 ACIP Meeting discussion of DPT risks and failures. Pgs. 34-37. NVIC.org.

¹⁸ Long SS, Lischner HW et al.Serologic evidence of subclinical pertussis in immunized children. Pediatr Infect Dis 1990; 9(10): 700-705.

¹⁹ Long SS, Welkon CJ, Clark JL. Widespread Silent Transmission of Pertussis in Families: Antibody Correlates of Infection and Symptomatology. J Infect Dis 1990; 161(3): 480-486.

²⁰ Christie C, Marx ML, Marchant CD et al. 1993 Epidemic of Pertussis in Cincinnati – Resurgence of Disease in a Highly Immunized Population of Children. NEJM 1994; 331: 16-21.

²¹ Mooi FR, van Oirschot H, Heuvelman K et al. Polymorphism in the Bordetella pertussis Virulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution. Infect Immun 1998; 66(2): 670-675.

²² Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 2013; 142(4): 672-684.

²³ Hinman A, Orenstein WA, Schuchat A.Vaccine Preventable Diseases, Immunization and MMWR 1961-2011. MMWR Oct. 7, 2011; 60(04): 49-57.

²⁴ Craig R, Kunkel E, Crowcroft NS et al. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. Clin Infect Dis 2020; 70(1): 152-161.

²⁵ U.S. Department of Health and Human Services (DHHS). Vaccines Protect You. Apr. 4. 2024.

²⁶ World Health Organization (WHO). Vaccines and immunization. 2025.

²⁷ Bullen M, Heriot GS, Jamrozik E. Herd immunity, vaccination and moral obligation. J Med Ethics 2023; 49(9): 636-641.

²⁸ Dunne CP, Spain e. Compulsory vaccination against COVID-19: A legal and ethical perspective on public good versus personal reticence. Ir j Med Sci 2022; 192(1): 221-226.

²⁹ Opel DJ, Reich JA, Peek ME. Amplifying Appeals to the Common Good in COVID-19 Vaccine Messaging. JAMA Health Forum 2022; 3(5.

³⁰ Paul Y. Herd immunity and herd protection. Vaccine 2004; 22(304): 301-302.

³¹ Columbia University. The Relationship Between Vaccines and Herd immunity. Mailman School of Public Health Apr. 9. 2021.

³² Bullen M, Heriot GS, Jamrozik E. Herd immunity, vaccination and moral obligation. J Med Ethics 2023; 49(9): 636-641.

³³ Choi J. Fauci: Vaccinated people become ‘dead ends’ for the coronavirus. The Hill May 16, 2021.

³⁴ Lybrand H. Fact check: Four times Walensky’s comments were out of step with CDC guidance. CNN May 21, 2021.

³⁵ Sherman A. Biden says that vaccinated people can’t spread Covid-19. That’s not what the CDC says. Politifact Dec. 22, 2021.

³⁶ Marcelin JR Pettifor A, Janes H et al. COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective. Open Forum Infect Dis Mar. 10, 2022.

³⁷ Acharya CB, Schrom J, Mitchell AM et al. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected with the SARS-CoV-2 Delta Variant. Open Forum Infect Dis May 2022; 9(5).

³⁸ Karlstad O, Hovi P, Husby A. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiology 2022; 7(6): 600-612.

³⁹ Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-Quadruplexes, exosomes and MicroRNAs. Food Chem Toxicol 2022; 164: 113008.

⁴⁰ Finsterer J. Neurological Adverse Reactions to SARS-CoV-2 Vaccines. Clin Psychopharmacol Neurosci 2023; 23(2): 222-239.

⁴¹ Fisher BL. Unknown Risks of COVID Shot Harm Revealed in New Report. The Vaccine Reaction May 13, 2024.

⁴² Culyba M, Van Tyne D. Bacterial evolution during human infection: Adapt and live or adapt and die. PLOS Pathogens 2021; 17((9).

⁴³ Belcher T, Dubois V, Rivera-Millot A et al. Pathogenicity and virulence of Bordetella pertussis and its adaptation to is strictly human host. Virulence 2021; 12(1): 2608-2632.

⁴⁴ Matthias J, Pritchard S, Martin SW et al. Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA . Emerging Infectious Diseases Jan. 15, 2016.

⁴⁵ Fisher BL. The Science and Politics of Eradicating Measles. National Vaccine Information Center May 25, 2019.

⁴⁶ Lopez-Perea PN, Fernandez-Garcia A, Echevarria JE et al. Measles in Vaccinated People: Epidemiology and Challenges in Surveillance and Diagnosis in the Post-Elimination Phase. Spain, 2014-2020. Viruses 2021; 13(10): 1982.

⁴⁷ Gouma S, Koopmans MPG, van Binnendijk RS. Mumps virus pathogenesis: Insights and knowledge gaps. Hum Vaccin Immunother 2016; 12(12): 3110-3112.

⁴⁸ White EB, Grant L, Mak J et al. Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection 2022-2023: A Prospective Cohort Study. Clin Infect Dis Oct. 24, 2024.

⁴⁹ Wendelboe AM, Van Rie A et al.Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(Suppl 5): S58-S61.

⁵⁰ Bianchi FP, Mascipinto S, Stefanizzi P et al. Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study. Hum Vaccin Immunother 2021; 17(7): 2078-2084.

⁵¹ Alexander PE. Why Does the CDC Recognize Natural Immunity for Chicken Pox but Not Covid? Brownstone Institute Sept. 17, 2021.

⁵² Transcript (partial) of May 12, 1986 ACIP Meeting discussion of DPT risks and failures. Pgs. 34-37. NVIC.org.

53 Klein N. Licensed Pertussis Vaccines in the U.S. Hum Vaccin Immunother 2014; 10(9): 2684-2690.

⁵⁴ Marwick C. Acellular Pertussis Vaccine Is Licensed for Infants. JAMA 1996; 276(7): 516-518.

⁵⁵ Kapil P, Merkel TJ. Pertussis Vaccines and Protective Immunity. Curr Opin Immunol 2019; 59: 72-78.

⁵⁶ Trollfors B. Bordetella pertussis whole cell vaccines – efficacy and toxicity. Acta paediatrica Scandinavia 1984; 73(4): 417-425.

⁵⁷ Wendelboe AM, Van Rie A et al.Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(Suppl 5): S58-S61.

⁵⁸ Klein NP, Bartless S, Fireman B, Baxter R.Waning Tdap Effectiveness in Adolescents. Pediatrics Feb. 3, 2016.

⁵⁹ Wearing HJ, Rohani P. Estimating the Duration of Pertussis Immunity by Epidemiological Signatures. PLoS Pathog 2009; 5(10).

⁶⁰ Cherry J. The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis and the Epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115(5): 1422-1427.

⁶¹ Craig R, Kunkel E, Crowcroft NS et al. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. Clin Infect Dis 2020; 70(1): 152-161.

⁶² Bart MJ, Harris SR, Advani A et al. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination . MBio 2014; 5(2).

⁶³ Hinman A, Orenstein WA, Schuchat A.Vaccine Preventable Diseases, Immunization and MMWR 1961-2011. MMWR Oct. 7, 2011; 60(04): 49-57.

64 CDC. Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2023–24 School Year. MMWR Oct. 17, 2024. 2024 / 73(41);925–932.

⁶⁵ CDC. Vaccine Coverage by Age 24 Months Among Children Born in 2019 and 2020 – National Immunization Survey – Child, United States, 2020-2022. Table 1. MMWR Nov. 3, 2023; 72(44): 1190-1196.

⁶⁶ CDC. National Vaccination Coverage Among Adolescents Aged 13-17 Years – National Immunization Survey – Teen, United States, 2023. MMWR Aug. 22, 2024; 73(33).

⁶⁷ Matthias J, Pritchard S, Martin SW et al. Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA . Emerging Infectious Diseases Jan. 15, 2016.

⁶⁸ Klein NP, Bartless S, Fireman B, Baxter R.Waning Tdap Effectiveness in Adolescents. Pediatrics Feb. 3, 2016.

⁶⁹ Skoff TH, Kenyon C, Cocoros N et al. Sources of Infant Pertussis Infection in the United States. Pediatrics 2015; 136(4): 635-641.

⁷⁰ Bart MJ, Harris SR, Advani A et al. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination . MBio 2014; 5(2).

⁷¹ Cleveland Clinic. Whooping Cough (Pertussis). Feb. 13, 2025.

⁷² CDC. Chapter 16: Pertussis. In: Epidemiology and Prevention of Vaccine-Preventable Diseases (14^th Edition) 2021.

⁷³ Marwick C. Acellular Pertussis Vaccine Is Licensed for Infants. JAMA 1996; 276(7): 516-518.

⁷⁴ Hoonakker ME. In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity. Toxins (Basel) 2021; 13(8): 565.

⁷⁵ Brito LA, Singh M. Acceptable levels of endotoxin in vaccine formulations during preclinical research. J Pharm Sci 2010; 100(1): 34-37.

⁷⁶ Johns Hopkins University. Vaccine Excipients by Excipient (Excipients in Routinely Recommended Vaccines). Institute for Vaccine Safety Apr. 7, 2025.

⁷⁷ Barkin RM, Pichichero ME. Diphtheria-Pertussis-Tetanus Vaccine: Reactogenicity of Commercial Products. Pediatrics 1979; 63(2).

⁷⁸ Cody CL, Baraff LJ, Cherry JD et al. Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children . Pediatrics 1981; 68(5).

⁷⁹ Miller DL, Ross EM, Alderslade R et al. Pertussis immunization and serious acute neurological illness in children. Brit Med J 1981; 282: 1595-1599.

⁸⁰ Institute of Medicine. DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis. Washington, D.C. The National Academies Press 1994.

⁸¹ Gustafsson L, Hallander HO, Olin P et al. A Controlled Trial of a Two-Component Acellular, A Five-Component Acellular, and a Whole Cell Pertussis Vaccine . New Engl J Med1996; 334(6): 349-355.

⁸² HRSA. Petitions Filed, Compensated and Dismissed by Alleged Vaccine, Since the Beginning of VICP, 10/01/1988 through 04/10/2025. National Vaccine Injury Compensation Program Monthly Statistics Report Apr. 1, 2025.

⁸³ CDC. DTaP (Diphtheria, Tetanus, Pertussis) Vaccine: What You Need to Know. Risks of a [DTaP] vaccine reaction. Vaccine Information Statement Aug. 24, 2018.

⁸⁴ Pellegrino P, Carnovale C, Perrone V et al. Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Event Reporting Systems. PLoS One 2013; 8(10).

⁸⁵ Baxter R, Lewis E, Goddard K et al. Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. Clin Infect Dis 2016; 63(11): 1456-1462,

⁸⁶ Virupakshaiah A, Moseley CE, Elicegui S et al. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol Neuroimmunol Neuroinflamm 2024; 11(4).

⁸⁷ Chard AN, Gacic-Dobo M, Diallo MS et al. Routine Vaccination Coverage – Worldwide 2019. MMWR Nov. 13, 2020; 69(45): 1706-1710.

⁸⁸ National Center for Health Statistics. U.S. Vital Statistics Mortality Data 1940-1949. Table 2 – Death Rates for Selected Causes, Whooping Cough (All Races, Both Sexes) 1948 . Pg. 38.

⁸⁹ Grove RD, Hetzel AM. Vital Statistics Rates in the United States 1940-1960. General Mortality (1921-1929), Section C, Table 65: Whooping Cough . Pg. 577. U.S. Public Health Service National Center for Health Statistics 1968.

⁹⁰ CDC. 2013 Final Pertussis Surveillance Report. Aug. 15, 2014.

⁹¹ CDC. 2024 Provisional Pertussis Surveillance Report. January 2025.

⁹² Cherry JD. The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection . Pediatrics 2005; 115(5).

⁹³ Macina D, Mathur S, Dvaretskaya M et al. Estimating the pertussis burden in adolescents and adults in the United States between 2007 and 2019. Hum Vaccin Immunother 2023; 19(1).

⁹⁴ Van der Zee A, Schellekens JF, Mooi FR. Laboratory Diagnosis of Pertussis. Clin Microbiol Rev 2015; 28(4): 1005-10026.

⁹⁵ Craig R, Kunkel E, Crowcroft NS et al. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. Clin Infect Dis 2020; 70(1): 152-161.

⁹⁶ Gunning CE, Gill CJ, Rohani P. Shining light on the dark matter of pertussis: evidence for an asymptomatic carriage state from a longitudinal cohort of mother/infant dyads. medRxiv Jan. 20, 2025.

⁹⁷ Kardos P, deSusa JC, Heininger D et al. Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations. Hum Vaccin Immunother 2024; 20(1).

⁹⁸ Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Disease in the United States: A Review of Measles and Pertussis. JAMA 2016; 315(11): 1149-1158.

⁹⁹ Edwards E. ‘Fighting to breathe’: Whooping cough surges as vaccination rate falters. NBC News Apr 21, 2025.

¹⁰⁰ Coote JG. Environmental sensing mechanisms in Bordetella. Adv Microb Physiol 2001; 44: 141-181.

¹⁰¹ Mooi FR, van Oirschot H, Heuvelman K et al. Polymorphism in the Bordetella pertussis Virulance Factors P. 69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution . Infection and Immunity 1998; 66(2): 670-675

¹⁰² dePaula BG, DeSousa RS, da Silva RCMR et al. fim3-24/ptxP-3 genotype is associated to whooping cough outbreak in Brazilian Midwest: The selection of Bordetella pertussis strains driven by vaccine immunization. Infection, Genetics and Evolution 2024; 121.

¹⁰³ de Celles MD, Magpantay FMG et al.The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc R Soc B 2016; 283.

¹⁰⁴ Kapil P, Merkel TJ. Pertussis Vaccines and Protective Immunity. Curr Opin Immunol 2019; 59: 72-78.

¹⁰⁵ Preston NW, Stanbridge TN. Efficacy of Pertussis Vaccines: A Brighter Horizon. Brit Med J 1972; 3:448-451.

¹⁰⁶ Broome CV, Preblud SR, Bruner B et al. Epidemiology of pertussis, Atlanta, 1977. J Pediatr 1981; 98(3): 362-267.

¹⁰⁷ Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9(5): 866-883.

¹⁰⁸ Greco D, Salmaso S, Mastrantonio P et al. A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine Against Pertussis . N Engl J Med 1996; 334(6): 341-348.

¹⁰⁹ Trollfors B. Bordetella pertussis whole cell vaccines – efficacy and toxicity. Acta paediatrica Scandinavia 1984; 73(4): 417-425.

¹¹⁰ CDC. Pertussis (Whooping Cough) Cases by Year (1922-2023). Apr. 24, 2025. 2025.

¹¹¹ Yih WK, Lett SM, desVignes FN et al. The increasing incidence of pertussis in Massachusetts adolescents and adults 1989-1998 . J Infect Dis 2000; 182(5): 1409-1416.

¹¹² Fine PEM, Clarkson JA. The Recurrence of Whooping Cough: Possible Implications for Assessment of Vaccine Efficacy . The Lancet 1982; 1(8273): 666-669.

¹¹³ Marchant CD, Loughlin AM, Lett SM et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness . J Infect Dis 1994; 169(6): 1297-1305.

¹¹⁴ Tanaka M, Vitek CR, Pascual B et al.Trends in Pertussis Among Infants in the United States, 1980-1999. JAMA 2003; 290)22): 2968-2975.

¹¹⁵ Yih WK, Lett SM, desVignes FN et al. The increasing incidence of pertussis in Massachusetts adolescents and adults 1989-1998 . J Infect Dis 2000; 182(5): 1409-1416.

¹¹⁶ Bouchez B, Guiso N. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. FEMS Pathogens and Disease Aug. 4, 2015 (online).

¹¹⁷ Christie CDC, Marx ML, Colin D et al. The 1993 Epidemic of Pertussis in Cincinnati. N Engl J Med 1994; 331: 16-21.

¹¹⁸ DeSerres G, Boulianne N et al. Pertussis in Quebec: ongoing epidemic since the late 1980’s . Can Commun Dis Rep 1995; 21(5): 45-48.

¹¹⁹ CDC. Pertussis Outbreak – Vermont, 1996. MMWR Sept. 5, 1997; 46(35): 822-826.

¹²⁰ Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence form a 10 year community study . Brit Med J 1988; 296: 612-614.

¹²¹ Barkin RM, Pichichero ME. Diphtheria-Pertussis-Tetanus Vaccine: Reactogenicity of Commercial Products. Pediatrics 1979; 63(2).

¹²² Cody CL, Baraff LJ, Cherry JD et al. Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children . Pediatrics 1981; 68(5).

¹²³ Miller DL, Ross EM, Alderslade R et al.Pertussis immunization and serious acute neurological illness in children. Brit Med J 1981; 282: 1595-1599.

¹²⁴ Institute of Medicine. DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis. Washington, D.C. The National Academies Press 1994.

¹²⁵ CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mar. 28, 1997;46(RR-7):1–25.

¹²⁶ Gustafsson L, Hallander HO, Olin P et al. A Controlled Trial of a Two-Component Acellular, A Five-Component Acellular, and a Whole Cell Pertussis Vaccine . New Engl J Med1996; 334(6): 349-355.

¹²⁷ Greco D, Salmaso S, Mastrantonio P et al. A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine Against Pertussis . N Engl J Med 1996; 334(6): 341-348.

¹²⁸ Zhang L, Prietsch SOM et al. Acellular vaccines for preventing whooping cough in children (Review). The Cochrane Library 2014 , Issue 9.

¹²⁹ Lavine J, Bjernstad O, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine . Vaccine 2012; 30(3): 544-551.

¹³⁰ Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014; 111(2): 787–792.

¹³¹ dePaula BG, DeSousa RS, da Silva RCMR et al. fim3-24/ptxP-3 genotype is associated to whooping cough outbreak in Brazilian Midwest: The selection of Bordetella pertussis strains driven by vaccine immunization. Infection, Genetics and Evolution 2024; 121.

¹³² Bouchez B, Guiso N.Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. FEMS Pathogens and Disease 2015; 73(7).

¹³³ CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR May 24, 2006;55(RR-3):1–34.

¹³⁴ CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC for Use of Tdap Among Health-Care Personnel. MMWR Dec. 15, 2006; 55(RR-17): 1-37.

¹³⁵ Wei SC, Tetti K, Cushing K et al. Effectiveness of Adolescent and Adult Tetanus Reduced-Dose Diphtheria and Acellular Pertussis Vaccine against Pertussis . Clin Infect Dis 2010; 51(3): 315-321.

¹³⁶ Mooi FR, van Oirschot H, Heuvelman K et al. Polymorphism in the Bordetella pertussis Virulance Factors P. 69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution . Infection and Immunity 1998; 66(2): 670-675.

¹³⁷ Simondon F, Guiso N. Genetic evolution under vaccine pressure: the Bordetella pertussis model. Bull Soc Pathol Exot 2000; 93(3): 202-205.

¹³⁸ De Melker HE, Schellekens JFP, Neppelenbroek SE et al. Reemergence of Pertussis in the Highly Vaccinated Population of the Netherlands: Observations on Surveillance Data. Emerg Infect Dis 2000; 6(4): 348-357.

¹³⁹ Mooi FR, vanLoo IHM, King AJ . Adaptation of Bordetella pertussis to vaccination: A Cause for Its Reemergence? Emerg Infect Dis 2001; 7(3): 526-528.

¹⁴⁰ Weber C, Boursaux-Eude C, Coralie G et al. Polymorphism of Bordetella pertussis Isolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years . J Clin Microbiol 2001; 39(12): 4296-4403.

¹⁴¹ Bart MJ, van Gent M, van der Heide HGJ et al. Comparative genomics of prevaccination and modern Bordetella pertussis strains . BMC Genomics 2010; 11: 627.

¹⁴² DeGouw D, Diavatopoulos DA, Bootsma HJ et al. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011; 35(2011): 441-474.

¹⁴³ Xu Y, Liu B et al. Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis . Sci Rep 2015; 5: 12888.

¹⁴⁴ Au Y, Zhou L, Du Q et al. Sharp rise in high-virulence Bordetella pertgussis with macrolides resistance in Northern China. Emerging Microbes Infections 2025; 14(1).

¹⁴⁵ Mooi FR, van Loo IHM, van Gent M et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence . Emerg Infect Dis 2009; 15(8): 1206-1213.

¹⁴⁶ Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen . Infect Genet Evol 2010; 10(1): 36-49.

¹⁴⁷ Bouchez V, Hegerle N, Strati F et al.New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. Vaccines (Basel) 2015; 3(3): 751-770.

¹⁴⁸ deCelles MD, Rohani P. Pertussis vaccines, epidemiology and evolution. Nature Reviews Epidemiology 2024; 222: 722-235.

¹⁴⁹ Mooi FR, van Loo IHM, van Gent M et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence . Emerg Infect Dis 2009; 15(8): 1206-1213.

¹⁵⁰ CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months --- Advisory Committee on Immunization Practices (ACIP), 2011 . MMWR Oct. 21, 2011; 60(41): 1424-1426.

¹⁵¹ Fisher BL. Vaccination During Pregnancy: Is It Safe? National Vaccine Information Center Nov. 9, 2013.

¹⁵² Fisher BL. If Vaccines Injure Pregnant Women or Their Unborn Babies: What Will the Vaccine Court Do? Presentation to the Health Resources Services Administration (HRSA) Sept. 17, 2018.

¹⁵³ Briga M, Goult E, Brett TS et al. Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study. Nature Communications 2024; 15(921).

¹⁵⁴ Rotimi CN, Jorde LB. Ancestry and Disease in the Age of Genomic Medicine. N Eng J Med 2010; 363(16).

¹⁵⁵ Fisher BL. Microbiologist Howard Urnovitz: Each Persons Unique Ancestral Genes Interact with Viruses to Cause Chronic Disease. The Vaccine Reaction Mar. 10, 2025.

¹⁵⁶ Farsetti A, Illi B, Gaetano C. How epigenetics impacts on human diseases. European Journal of Internal Medicine 2023; 114: 15-22.

¹⁵⁷ Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015; 31(1): 69-75.

¹⁵⁸ Liu L, Juj JR, Shah K. Microbiota and the gut-brain axis: Implications for new therapeutic design in the CNS. eBioMedicine 2022; 77(103908).

¹⁵⁹ Fisher BL. The Disappearing Medical Exemption to Vaccination. National Vaccine Information Center Sept. 17, 2019.

¹⁶⁰ NVIC. National Vaccine Information Center Supports Three of Five Recommendations of New IOM Report on U.S. Childhood Immunization Schedule Safety and Calls for Transparency. Businesswire Jan. 16, 2013.

¹⁶¹ Fisher BL. WHO, Pharma, Gates & Government: Who’s Calling the Shots? National Vaccine Information Center Jan. 27, 2019.

¹⁶² Schmitt P, Borkner L, Jazayeri SD et al. Nasal vaccines for pertussis. Curr Opin Immunol 2023; 84(102355).

¹⁶³ Aibani N, Patel P, Buchanen R et al. Assessing the In vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis. Mol Pharm 2022; 19(6): 1814-1824.

¹⁶⁴ Moghimi SM, Simbert D. Pro-inflammatory concerns with lipid nanoparticles. Mol Ther 2022; 30(6): 2109-2110.

¹⁶⁵ Trougakos IP, Terpos E, Alexopoulos H et al. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med 2022; 28(7): 542-544.

¹⁶⁶ Wolf MA, O’Hara JM, Bitzer GJ et al. Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice. npj Vaccines 2024; 9(103).

¹⁶⁷ Strom J. Is Universal Vaccination Against Pertussis Always Justified? BMJ Oct. 22, 1960.

¹⁶⁸ Fisher BL. The 1986 National Childhood Vaccine Injury Act: MYTH vs. FACT. National Vaccine Information Center Jan. 4, 2024.

¹⁶⁹ Fisher BL. The Moral Right to Conscientious, Philosophical and Personal Belief Exemption to Vaccination. Presentation to National Vaccine Advisory Committee May 2, 1997.

VIDEO: The Truth About Whooping Cough in the U.S. / NVIC, Rumble